Hepatocellular Carcinoma in Patients with NAFLD – Emerging Risk Factors
Non-alcoholic fatty liver disease (NAFLD) now drives many cases of hepatocellular carcinoma (HCC). Doctors observe a steady rise in HCC among NAFLD patients worldwide. Moreover, this trend appears even without cirrhosis in many cases.
Furthermore, obesity plays a major role in this link. Excess body fat leads to chronic inflammation in the liver. As a result, the risk of cancer development increases significantly over time.
In addition, insulin resistance and type 2 diabetes strongly contribute to the problem. These conditions promote abnormal cell growth in the liver. Therefore, patients with metabolic disorders face higher chances of developing HCC.
Moreover, gut microbiome changes emerge as a new risk factor. Imbalanced bacteria in the digestive system trigger harmful inflammation. This process can accelerate liver damage and cancer formation.
Additionally, genetic factors influence individual risk levels. Certain gene variations make some NAFLD patients more vulnerable to HCC. Researchers actively study these genes to improve early detection.
Furthermore, lifestyle elements such as poor diet and lack of physical activity worsen the situation. Processed foods and sedentary habits speed up liver fat accumulation. Consequently, they raise the overall cancer threat.
Experts also highlight the role of aging. Older NAFLD patients show faster disease progression toward cancer. Therefore, regular screening becomes essential for this group.
Overall, NAFLD-related HCC represents a growing global health challenge. Early identification of these emerging risk factors can help doctors prevent and manage the disease more effectively. Researchers continue to explore new ways to reduce this rising burden.